Colorectal carcinoma is the most frequent type of bowel cancer and the second most common tumour disease among men and women in Germany. So-called microsatellite stable colorectal cancer with mutations in the BRAF gene represents a particularly aggressive form. The BRAF gene produces the enzyme B-Raf, ...
Drug-Resistant Melanoma Treatment May Be Enhanced: Study - More than 8,000 Americans are killed each year by melanoma — the deadliest form of skin cancer. The presence of mutations in a gene known as the BRAF gene drives approximately 40 percent of advanced melanoma tumors. | RedOrbit/Nov 2013
BRAF DISCOVERY - We helped fund the ground breaking study that identified faults in the BRAF gene as a key cause of malignant melanoma. This led to the development of the drug vemurafenib. Read the full story here: http://scienceblog.cancerresearchuk.org/2009/08/24/high-impact-science-%E2%80%93-finding-faults-in-braf/#
There are two different subtypes of #Craniopharyngioma (CP): papillary (papCP) and adamantinomatous (adaCP) which harbor distinctive gene mutations. BRAF V600E mutations were solely found in the papCP subgroup and were not detectable in adaCP samples. In contrast, CTNNB1 mutations were exclusively detected in adaCP. (Read full article (open access) inside, published Feb 2016)